TSHA
Taysha Gene Therapies Inc
4.40$
+0.9%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -11.8% | -11.4% | +31.0% | -10.1% | -11.0% | -13.7% | +140.9% | -5.0% | +8.5% | -12.5% | +56.6% | |
| – | -12.8% | -12.9% | +36.7% | -9.5% | -12.0% | -15.1% | +162.0% | -5.2% | +8.2% | -13.1% | +63.5% | |
| – | -12.4% | -13.9% | +39.3% | -8.7% | -11.8% | -16.1% | +168.3% | -4.9% | +7.5% | -13.5% | +64.7% | |
| – | -12.4% | -13.9% | +39.3% | -8.7% | -11.8% | -16.1% | +168.3% | -4.9% | +7.5% | -13.5% | +64.7% | |
| – | -60.1% | +1.4% | -7.7% | -0.1% | -2.8% | -6.2% | +1.6% | +15.3% | -1.2% | -8.3% | -5.9% | |
| – | -79.6% | +5.1% | -11.5% | -14.2% | -10.6% | -14.0% | +12.4% | +12.9% | -7.3% | -24.3% | +29.2% | |
| – | +7.0% | +3.0% | +3.4% | +3.5% | +3.4% | -3.7% | -3.9% | -4.0% | – | – | – | |
| – | -15.3% | +63.1% | -16.0% | -43.4% | -27.2% | +20.4% | +78.3% | -29.5% | +15.4% | -27.3% | +100.8% | |
| – | +5.1% | +0.0% | -6.6% | +13.6% | +2.3% | -3.4% | -3.3% | +23.9% | -1.5% | -2.3% | +0.6% | |
| – | – | -28.1% | +102.2% | -18.4% | -19.5% | -23.0% | +351.7% | -12.0% | +12.8% | -14.2% | +82.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +48.7% | +23.7% | +0.7% | +15.0% | -23.5% | +31.4% | +10.7% | +18.6% | -9.5% | +14.7% | +0.7% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.